Vericiguat-new treatment option for patients with heart failure Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA)

被引：0
|
作者：
Bauersachs, J. [1 ]
Nitschmann, S. [1 ]
机构：
[1] Hannover Med Sch, Klin Kardiol & Angiol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
INTERNIST | 2020年 / 61卷 / 09期
关键词：
D O I：
10.1007/s00108-020-00828-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：989 / 991
页数：3
相关论文
共 50 条
  • [21] Vericiguat: The Fifth Harmony of Heart Failure with Reduced Ejection Fraction
    Falco, Luigi
    Brescia, Benedetta
    Catapano, Dario
    Martucci, Maria Luigia
    Valente, Fabio
    Gravino, Rita
    Contaldi, Carla
    Pacileo, Giuseppe
    Masarone, Daniele
    [J]. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (09)
  • [22] Drug Treatment of Heart Failure with Reduced Ejection Fraction: Defining the Role of Vericiguat
    Coats, Andrew J. S.
    Tolppanen, Heli
    [J]. DRUGS, 2021, 81 (14) : 1599 - 1604
  • [23] Cost Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: Results From the VICTORIA Trial
    Chew, Derek S.
    Cowper, Patricia A.
    Bigelow, Robert
    Li, Yanhong
    Anstrom, Kevin
    Davidson-Ray, Linda D.
    Hernandez, Adrian F.
    O'Connor, Christopher M.
    Armstrong, Paul
    Mark, Daniel B.
    [J]. CIRCULATION, 2021, 144 (25) : E586 - E586
  • [24] Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction
    Meyer, M.
    Ruehs, H.
    Klein, D.
    Frei, M.
    Garmann, D.
    Grevel, J.
    Austin, R.
    Becker, C.
    Roessig, L.
    Pieske, B.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 376 - 376
  • [25] Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
    Saldarriaga, Clara
    Atar, Dan
    Stebbins, Amanda
    Lewis, Basil S.
    Abidin, Imran Zainal
    Blaustein, Robert O.
    Butler, Javed
    Ezekowitz, Justin A.
    Hernandez, Adrian F.
    Lam, Carolyn S. P.
    O'Connor, Christopher M.
    Pieske, Burkert
    Ponikowski, Piotr
    Roessig, Lothar
    Voors, Adriaan A.
    Anstrom, Kevin J.
    Armstrong, Paul W.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (05) : 782 - 790
  • [26] Drug Treatment of Heart Failure with Reduced Ejection Fraction: Defining the Role of Vericiguat
    Andrew J. S. Coats
    Heli Tolppanen
    [J]. Drugs, 2021, 81 : 1599 - 1604
  • [27] EJECTION FRACTION, BIOMARKERS, AND OUTCOMES IN HEART FAILURE WITH REDUCED EJECTION FRACTION AND THE IMPACT OF VERICIGUAT ON OUTCOMES IN THE VICTORIA TRIAL
    Butler, Javed
    Zheng, Yinggan
    Bonderman, Diana
    Lund, Lars
    DeFilippi, Christopher R.
    Blaustein, Robert
    Ezekowitz, Justin A.
    Freitas, Cecilia
    Hernandez, Adrian F.
    O'Connor, Christopher M.
    Voors, Adriaan
    Westerhout, Cynthia M.
    Lam, Carolyn S. P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 372 - 372
  • [28] Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trial
    Ponikowski, Piotr
    Alemayehu, Wendimagegn
    Oto, Ali
    Bahit, M. Cecilia
    Noori, Ebrahim
    Patel, Mahesh J.
    Butler, Javed
    Ezekowitz, Justin A.
    Hernandez, Adrian F.
    Lam, Carolyn S. P.
    O'Connor, Christopher M.
    Pieske, Burkert
    Roessig, Lothar
    Voors, Adriaan A.
    Westerhout, Cynthia
    Armstrong, Paul W.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (08) : 1300 - 1312
  • [29] Evaluating haemodynamic changes: vericiguat in patients with heart failure with reduced ejection fraction
    Suzuki, Hideaki
    Inoue, Takumi
    Terui, Yousuke
    Takeuchi, Kouki
    Susukita, Kai
    Arai, Marina
    Sato, Haruka
    Satoh, Taijyu
    Yamamoto, Saori
    Yaoita, Nobuhiro
    Tatebe, Shunsuke
    Hayashi, Hideka
    Nochioka, Kotaro
    Takahama, Hiroyuki
    Yasuda, Satoshi
    [J]. ESC HEART FAILURE, 2024, 11 (04): : 2451 - 2454
  • [30] Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
    Hauke Ruehs
    Dagmar Klein
    Matthias Frei
    Joachim Grevel
    Rupert Austin
    Corina Becker
    Lothar Roessig
    Burkert Pieske
    Dirk Garmann
    Michaela Meyer
    [J]. Clinical Pharmacokinetics, 2021, 60 : 1407 - 1421
12345